Multiple Chronic Conditions Blog
First ER Morphine Designed to Deter Abuse When Crushed
The Food and Drug Administration (FDA) has approved new labeling for Embeda (morphine sulfate and naltrexone HCl; Pfizer) extended-release (ER) capsules to include abuse-deterrence studies.
Dr Kim Kuebler
Dr. Kim Kuebler DNP, APRN, ANP-BC, FAAN, Founder and Director Multiple Chronic Conditions Resource Center, CEO Advanced Disease Concepts, LLC., Award winning author of 8 textbooks on chronic conditions and palliative care. Multiple appointments to Federal and state initiatives on pain, chronic conditions and palliative care. Clinician, educator, researcher and patient advocate.